Dr. Anna Wrobeln and Priv.-Doz. Dr. Freya Dröge from the University of Duisburg-Essen - Funded!

Published on May 23, 2024

The University of Duisburg-Essen posted an article featuring two HHT researchers - Dr. Anna Wrbeln and Dr. Freya Dröge. 

Click here to read more about their funded work to study HIF stabilization and the hypothesis it will improve cellular immunometaboilsm for HHT patients! 

There is also an opportunity to do a PhD in their laboratory! Click Here for the job description and application. 

Congratulations to Freya and Anna - Thank you for the work you are doing to better understand HHT!

Other news

Sekarski Spreads HHT Awareness

May 6, 2024
Sekarski_et_al_2024.pdfThank you, Lynne Sekarski, for spreading awareness about HHT through your recently published case report and presentation at the Society of Pediatric Nurses conference. Please read and share with a colleague who does not work with HHT patients. I will be sharing this with a friend who is an emergency room nurse. Remember, when we diagnose 1 person with HHT, we likely diagnos

Consensus Guidelines for Variant Interpretation in ENG and ACVRL1

May 30, 2024
A group of HHT researchers was assembled to serve on a 'Variant Curation Expert Panel (VCEP)' to develop criteria for evaluating the pathogenicity of variants in ENG and ACVRL1 and to review variants in the ClinGen database. Their recent publication details the modifications made to variant interpretation guidelines of the American College of Medical Genetics and Genomics (ACMG) and the Associatio